Literature DB >> 2305263

Ligand-induced transformation by a noninternalizing epidermal growth factor receptor.

A Wells1, J B Welsh, C S Lazar, H S Wiley, G N Gill, M G Rosenfeld.   

Abstract

Identification of a mutant epidermal growth factor (EGF) receptor that does not undergo downregulation has provided a genetic probe to investigate the role of internalization in ligand-induced mitogenesis. Contact-inhibited cells expressing this internalization-defective receptor exhibited a normal mitogenic response at significantly lower ligand concentrations than did cells expressing wild-type receptors. A transformed phenotype and anchorage-independent growth were observed at ligand concentrations that failed to elicit these responses in cells expressing wild-type receptors. These findings imply that activation of the protein tyrosine kinase activity at the cell membrane is sufficient for the growth-enhancing effects of EGF. Thus, downregulation can serve as an attenuation mechanism, without which transformation ensues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305263     DOI: 10.1126/science.2305263

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  108 in total

1.  The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.

Authors:  H Waterman; I Alroy; S Strano; R Seger; Y Yarden
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.

Authors:  Sandrine Roy; Bruce Wyse; John F Hancock
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

3.  Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway.

Authors:  Sumedha G Penheiter; Hugh Mitchell; Nandor Garamszegi; Maryanne Edens; Jules J E Doré; Edward B Leof
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

4.  Autocrine ligand binding to cell receptors. Mathematical analysis of competition by solution "decoys".

Authors:  K E Forsten; D A Lauffenburger
Journal:  Biophys J       Date:  1992-02       Impact factor: 4.033

5.  Multiple functions of let-23, a Caenorhabditis elegans receptor tyrosine kinase gene required for vulval induction.

Authors:  R V Aroian; P W Sternberg
Journal:  Genetics       Date:  1991-06       Impact factor: 4.562

6.  Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies.

Authors:  Jeonghee Cho; Sandra Pastorino; Qing Zeng; Xiaoyin Xu; William Johnson; Scott Vandenberg; Roel Verhaak; Andrew D Cherniack; Hideo Watanabe; Amit Dutt; Jihyun Kwon; Ying S Chao; Robert C Onofrio; Derek Chiang; Yuki Yuza; Santosh Kesari; Matthew Meyerson
Journal:  Cancer Res       Date:  2011-10-14       Impact factor: 12.701

7.  A site of tyrosine phosphorylation in the C terminus of the epidermal growth factor receptor is required to activate phospholipase C.

Authors:  Q C Vega; C Cochet; O Filhol; C P Chang; S G Rhee; G N Gill
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

8.  Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.

Authors:  Maria Sundvall; Anna Korhonen; Ilkka Paatero; Eugenio Gaudio; Gerry Melino; Carlo M Croce; Rami I Aqeilan; Klaus Elenius
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

9.  Systems biological analysis of epidermal growth factor receptor internalization dynamics for altered receptor levels.

Authors:  Hannah Schmidt-Glenewinkel; Eileen Reinz; Roland Eils; Nathan R Brady
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

10.  Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Authors:  A E Lenferink; R Pinkas-Kramarski; M L van de Poll; M J van Vugt; L N Klapper; E Tzahar; H Waterman; M Sela; E J van Zoelen; Y Yarden
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.